Leveraging New Therapeutic Modalities to expand the Druggable Target Space

3/9/2020 08:50 - 09:25

  • Innovation through new therapeutic modalities
  • Current landscape of oligonucleotide therapeutics, opportunities and the challenges
  • The promise of mRNA therapeutics and delivery hurdles
  • Future outlook

Please note that this will be a remote presentation

Shalini Andersson, Chief Scientist New Therapeutic Modalities, AstraZeneca

Back to programme